XML 37 R25.htm IDEA: XBRL DOCUMENT

Equity Investment	12 Months Ended
Dec. 31, 2022
Investments, All Other Investments [Abstract]
Equity Investment	(16) Equity Investments In February 2016, AMVAC BV made an equity investment of $3,283 in Biological Products for Agriculture (“Bi-PA”). Bi-PA develops biological plant protection products that can be used for the control of pests and disease of agricultural crops. As of December 31, 2022, 2021 and 2020, the Company’s ownership position in Bi-PA was 15%. Since this investment does not have readily determinable fair value, the Company has elected to measure the investment at cost less impairment, if any, and to record an increase or decrease for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of Bi-PA. The Company periodically reviews the investment for possible impairment. The Company recorded an impairment charge in the amount of $399 during the year ended December 31, 2021. There were no impairment or observable price changes on the investment during the years ended December 31, 2022 and 2020. The investment is recorded within other assets on the consolidated balance sheets and amounted to $2,884 as of December 31, 2022 and 2021. On April 1, 2020, AMVAC purchased 6.25 million shares, an ownership of approximately 8%, of common stock of Clean Seed Capital Group Ltd. (TSX Venture Exchange: “CSX”) for $1,190. The shares are publicly traded, have a readily determinable fair value, and are considered a Level 1 investment. The fair value of the stock amounted to $784 and $1,516 as of December 31, 2022 and 2021, respectively, and the Company recorded losses of $732 and $391 and a gain of $717 for the years ended December 31, 2022, 2021 and 2020, respectively. The investment is recorded within other assets on the consolidated balance sheets and amounted to $784 and $1,516 as of December 31, 2022 and 2021, respectively.

Equity Investment

12 Months Ended

Dec. 31, 2022

Investments, All Other Investments [Abstract]

(16) Equity Investments

In February 2016, AMVAC BV made an equity investment of $3,283 in Biological Products for Agriculture (“Bi-PA”). Bi-PA develops biological plant protection products that can be used for the control of pests and disease of agricultural crops. As of December 31, 2022, 2021 and 2020, the Company’s ownership position in Bi-PA was 15%. Since this investment does not have readily determinable fair value, the Company has elected to measure the investment at cost less impairment, if any, and to record an increase or decrease for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of Bi-PA. The Company periodically reviews the investment for possible impairment. The Company recorded an impairment charge in the amount of $399 during the year ended December 31, 2021. There were no impairment or observable price changes on the investment during the years ended December 31, 2022 and 2020. The investment is recorded within other assets on the consolidated balance sheets and amounted to $2,884 as of December 31, 2022 and 2021.

On April 1, 2020, AMVAC purchased 6.25 million shares, an ownership of approximately 8%, of common stock of Clean Seed Capital Group Ltd. (TSX Venture Exchange: “CSX”) for $1,190. The shares are publicly traded, have a readily determinable fair value, and are considered a Level 1 investment. The fair value of the stock amounted to $784 and $1,516 as of December 31, 2022 and 2021, respectively, and the Company recorded losses of $732 and $391 and a gain of $717 for the years ended December 31, 2022, 2021 and 2020, respectively. The investment is recorded within other assets on the consolidated balance sheets and amounted to $784 and $1,516 as of December 31, 2022 and 2021, respectively.